Cleared Traditional

CAAS QVA 3D, CAAS QCA 3D (K100292) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K100292 · Pie Medical Imaging BV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
87d
Days
Class 2
Risk

K100292 is an FDA 510(k) clearance for the CAAS QVA 3D, CAAS QCA 3D. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Pie Medical Imaging BV (Maastricht, NL). The FDA issued a Cleared decision on April 30, 2010 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Pie Medical Imaging BV devices

Submission Details

510(k) Number K100292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2010
Decision Date April 30, 2010
Days to Decision 87 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 107d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 731
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K100292.
SYNGO MBF
K110494 · Siemens Medical Solutions USA, Inc. · Apr 2011
SYNGO DYNAMICS, VERSION 9.0
K102150 · Siemens Medical Solutions USA, Inc. · Oct 2010
SYMBIA.NET, SYMBIA.NET SELECT MODEL 10520828, 10520827
K100619 · Siemens Medical Solutions USA, Inc. · May 2010
STORM-BASE 2.0
K093603 · KARL STORZ Endoscopy-America, Inc. · Mar 2010
SYNGO.PET&CT ONCOLOGY
K093621 · Siemens Medical Solutions USA, Inc. · Feb 2010
SYNGO TRUED
K091373 · Siemens Medical Solutions USA, Inc. · May 2009